Dec 31 2024
SciSparc Ltd., a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, has received renewed approval from the Israeli Medical Cannabis Agency to conduct a clinical trial of SCI-210, a CBD and CannAmide combination, for children with autism spectrum disorder (ASD). This renewal reaffirms the Company’s …
Dec 31 2024
A new study suggests cannabidiol (CBD) could be a game-changer in fighting gum disease, showing significant antibacterial and antibiofilm effects against harmful oral bacteria. Researchers from Brazil’s Federal University of São João del Rei and Universidade Federal de Uberlândia found CBD to be both effective and non-toxic, highlighting its potential as a therapeutic option for …
Dec 30 2024
The University of California San Diego (UCSD) is seeking participants for six marijuana-related clinical trials. The university is currently conducting seven clinical trials related to marijuana and its compounds, with all but one currently open to new participants (the seventh is “currently not accepting new patients, but might later”). Below is a breakdown of these …
Dec 30 2024
The University of California San Francisco (UCSF) is seeking participants for four clinical trials exploring the effects of psilocybin on mental health conditions and chronic low back pain. The university is currently conducted eight clinical trial related to psilocybin, with two “in progress, not accepting new patients”, two that are “not yet accepting patients”, and …
Dec 29 2024
A new study reveals that legalizing recreational marijuana may cut opioid-related deaths by an average of 3.5 per 100,000 residents. The research, based on state-level data from the U.S. Centers for Disease Control and Prevention, found the most significant impact in states that legalized marijuana earlier in the opioid crisis. According to the study, the …
Dec 29 2024
Researchers from the Beijing Institute of Radiation Medicine have found that cannabidiol (CBD)-loaded hollow suppositories using 3D printing technology may be effective in treating epilepsy. Published in the International Journal of Pharmaceutics, the study highlights the limitations of traditional oral CBD formulations, which often face significant first-pass metabolic effects, reducing their efficacy. The newly designed …
Dec 28 2024
A study published in the journal Pharmacy has validated a new method for accurately quantifying cannabinoids in commercial veterinary CBD oil. According to its abstract, the study “highlights the need for quality control in evaluating medicinal plant products, especially CBD oils, before market release”, noting that “Due to varying regulatory requirements, product labeling can sometimes …
Dec 27 2024
A new study has found that cannabidiol (CBD), a compound derived from marijuana, may help combat depression and memory issues triggered by prolonged social isolation. Researchers from the Federal University of Ouro Preto and the Laboratory of Neurobiology and Biomaterials found that CBD offered significant antidepressant and neuroprotective effects in male mice subjected to chronic …
Dec 26 2024
According to the results of a new study, “cannabis-based medicines may be effective in treating the pain and symptoms of peripheral neuropathy”. Published by Journal of Hand Surgery, the study is titled The Use of Cannabinoids in the Treatment of Peripheral Neuropathy and Neuropathic Pain: A Systematic Review. It was conducted by researchers from University …
Dec 22 2024
Despite marijuana remaining a Schedule I drug on the federal level, 2024 has been a huge year for marijuana research. As marijuana moves closer to being rescheduled to Schedule III, the potential for easier and more comprehensive research on marijuana and its compounds appears to be on the horizon. While this change has not yet …
